Insulet Extends Exclusive Agreement for Blood Glucose Monitoring
Continues Integration of Abbott’s FreeStyle(R) Technology with Insulet’s OmniPod(R) Insulin Management System BILLERICA, MA — (Marketwired) — 02/03/15 — Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its OmniPod®Insulin Management System, today announced that it has…
Read more